A deal or initiative is margin accretive when it lifts the combined business’s profit margin percentage above what the acquirer earned on its own. If a company running a 15% operating margin buys a business running at 25%, the blended result lands somewhere between the two, and because that blend is higher than where the buyer started, the transaction is margin accretive. The same logic applies inside a single company: a new product line, geography, or division that earns a higher margin than the company average pulls the overall margin up.
The test is a comparison, not a threshold. You are not asking whether the target is profitable, or whether it earns some particular margin. You are asking whether folding it in moves the acquirer’s margin percentage up or down.
Accretive, Dilutive, and the Weighted Average Between Them
Dilution is the mirror image. When the target or new venture runs at a thinner margin than the acquirer, the blend pulls the combined margin below where the acquirer started. A company earning a 20% operating margin that acquires a business earning 12% will post a blended margin under 20%.
Executives sometimes accept dilution on purpose. The target might open a fast-growing market, lock down a critical supplier, or bring in technology that will lift margins over several years. But immediate dilution tends to pressure the stock, and management has to tell a convincing story about when and how margins recover.
Because the calculation is a revenue-weighted average, the relative size of the two businesses matters as much as the gap between their margins. A small, very high-margin target can be accretive without meaningfully moving the combined number. A large target with a modest margin advantage can shift the blend substantially.
How Margin Accretion Differs From EPS Accretion
Most accretion analysis on Wall Street tracks earnings per share rather than margin. EPS accretion asks whether the combined company’s earnings per share exceed the buyer’s standalone EPS before the deal. The two measures answer different questions and can point in opposite directions on the same transaction.
EPS accretion depends heavily on how the deal is paid for. Stock consideration dilutes the share count, which can make a deal EPS-dilutive even when the target is highly profitable. Cash or debt avoids share dilution but introduces interest expense. The standard EPS test compares the weighted after-tax cost of the acquisition funding against the target’s earnings yield at the purchase price; if the yield exceeds the blended cost, the deal is EPS accretive.
Margin accretion ignores capital structure entirely. It looks only at operating economics: does the target earn a higher percentage on its revenue than the acquirer? That makes it a cleaner read on operational fit, but an incomplete read on shareholder impact. A deal can look strong on margins while the financing quietly erodes earnings per share. Serious analysis runs both.
Which Margin You Measure Changes the Answer
There is no single “margin.” Accretion can be tested at the gross, operating, EBITDA, or net level, and the same deal can be accretive at one level and dilutive at another. The right choice depends on what you are trying to learn.
Gross Margin
Gross margin is revenue minus cost of goods sold, as a percentage of revenue. It measures how efficiently a company converts inputs into sellable products before overhead enters the picture. A target with a higher gross margin than the acquirer signals better pricing power or lower production cost, and folding it in will improve the combined gross margin.
The limit of gross margin analysis: it says nothing about whether the target carries a bloated sales organization or spends heavily on R&D. Two companies with the same gross margin can look very different one line down.
Operating Margin
Operating margin subtracts both cost of goods sold and all operating expenses, including salaries, rent, marketing, and research. For most deals, this is the most useful level for accretion analysis, because it captures whether the target’s whole business model is more efficient than the acquirer’s, not just its production economics.
Operating margin is also where cost synergies show up most directly. Acquirers planning to cut duplicated corporate functions after closing will see those savings in operating expenses rather than in cost of goods sold.
EBITDA Margin
Businesses with heavy capital investment, such as software platforms, telecom networks, and large manufacturing operations, often focus on EBITDA margin: earnings before interest, taxes, depreciation, and amortization. Removing depreciation and amortization lets buyers compare the core cash-generating ability of two businesses without the noise of different asset ages, depreciation schedules, or accounting treatment of past acquisitions.
EBITDA has real limits. The SEC has issued guidance requiring non-GAAP measures like EBITDA to be reconciled to the most directly comparable GAAP figure, which is net income rather than operating income, and presented with equal or lesser prominence than the GAAP number.1U.S. Securities and Exchange Commission. Non-GAAP Financial Measures “Adjusted EBITDA” that strips out recurring operating costs can present a target’s profitability more favorably than it deserves. Buyers who rely on aggressive add-backs, removing expenses that management labels one-time but that recur suspiciously often, sometimes discover after closing that the target’s true margins are lower than the model assumed.
Net Margin
Net margin is net income divided by revenue, capturing everything: cost of goods, operating expenses, interest, and taxes. A deal that is accretive at the operating level can flip to dilutive at the net margin level once the interest cost of the debt used to fund it is factored in. Public investors tend to concentrate here, because net income is what drives earnings per share.
Running the Calculation
The mechanics are a revenue-weighted average. Add the dollar profits of both businesses, add their revenues, divide, and compare the result to the acquirer’s standalone margin.
Company A has $500 million in revenue and $100 million in operating profit, a 20% operating margin. Target T has $100 million in revenue and $30 million in operating profit, a 30% operating margin.
Combined operating profit comes to $130 million. Combined revenue comes to $600 million. The blended operating margin is $130 million divided by $600 million, or 21.7%. That exceeds Company A’s standalone 20%, so the transaction is operating margin accretive.
Look at the sizing. Target T’s margin is ten full points above Company A’s, and yet the blend improves by only 1.7 percentage points, because Company A contributes five times more revenue. A small, high-margin target can be accretive without meaningfully moving the needle. If moving the needle is the point, the target has to be a meaningful share of combined revenue.
Factoring In Financing
The raw blend above treats the deal as if it were free. In practice, the buyer pays with some mix of cash, debt, and stock, and each has a cost that can bite into accretion once you get below the operating line.
Suppose Company A funds the acquisition with $500 million of new debt at 5%. That adds $25 million in annual interest expense. Combined operating profit stays at $130 million, so the operating margin accretion is unchanged. Net income, however, now absorbs the $25 million, which can make the same deal net margin dilutive, a result that matters to shareholders and public market analysts.
Stock financing avoids interest expense but dilutes the share count, which is why equity-funded deals can be margin accretive and EPS dilutive at the same time. Thorough deal models test accretion at every margin level under multiple financing mixes before the acquirer commits.
Why Accretive Deals Can Still Destroy Value
This is where the metric fools people. A deal can be margin accretive on Day 1 and still destroy shareholder value, because margin accretion says nothing about the price paid. Pay a 50% premium for a high-margin target and the return on invested capital may fall well below the company’s cost of capital, even as the blended margin looks better on paper.
Research consistently finds that somewhere between 70% and 75% of acquisitions fail to achieve their stated objectives of enhancing growth, cutting costs, or holding the buyer’s share price. The disconnect often comes from management optimizing for visible metrics like revenue growth, margin improvement, or non-GAAP income, rather than whether the deal earns a return above the capital deployed. A margin accretive deal priced on unrealistic growth assumptions is a value trap with better optics.
The practical read: margin accretion is a necessary sanity check, not a sufficient one. The deal should pass it, but passing it is not permission to proceed. The purchase price still has to make sense against the cash flows the target will actually produce.
Synergies and Integration Costs Change the Realized Number
Almost every acquisition pitch includes a slide showing margin improvement from synergies, the cost savings and revenue gains that are supposed to arrive after the two companies combine. Projected accretion and realized accretion often part ways here.
Cost synergies, such as eliminating duplicate headquarters, renegotiating supplier contracts, consolidating IT, and reducing overlapping headcount, tend to be the more achievable kind. Early wins can emerge within three to six months of closing. Deeper operational integration takes longer and has to be executed without disrupting the underlying businesses.
Revenue synergies, the expectation that the combined company will sell more than the two did separately, are much harder to capture. A Bain survey of 281 executives found that overestimating revenue synergies was the single most cited reason for unsuccessful deals, and yet only half of those executives said they included revenue synergies in their deal models at all. The logic sounds compelling (cross-selling, bundled products, expanded distribution), but execution depends on customer behavior neither company fully controls.
Integration costs are the other side. IT migration, facility consolidation, severance, rebranding, and consultant fees are real cash outflows. They typically run between 1% and 7% of deal value and hit in the first one to three years, exactly when synergies are still being realized. Customer attrition compounds the problem: after a merger, some customers leave because they are uncomfortable concentrating spend with a single vendor, or because they anticipate reduced service during integration. Lost revenue against the same fixed cost base compresses margins in the opposite direction the deal was supposed to go.
When comparing a pre-deal accretion model to post-close reality, the gap usually sits in these three places: synergies that came in smaller or later than projected, integration costs that were understated, and customer losses that nobody modeled.